Literature DB >> 9077609

Cancer risk after a hospital discharge diagnosis of endometriosis.

L A Brinton1, G Gridley, I Persson, J Baron, A Bergqvist.   

Abstract

OBJECTIVES: Our goal was to determine the risk of cancer after hospitalization for endometriosis. STUDY
DESIGN: Records of 20,686 women hospitalized with endometriosis during the period 1969 to 1983, as identified through the nationwide Swedish Inpatient Register, were linked against the National Swedish Cancer Registry through 1989 to identify all subsequent diagnoses of cancer. The study subjects were followed up for a mean of 11.4 years, with the cohort contributing 216,851 woman years of follow-up. Standardized incidence ratios were computed by the use of age- and period-specific incidence rates derived from the Swedish population. Because of the high proportion of subjects with gynecologic operations (55.6%), evaluation of the risk of gynecologic cancers involved truncation of person years at the time of any such operation.
RESULTS: The overall cancer risk was 1.2 (95% confidence interval 1.1 to 1.3). Significant excesses were observed for breast cancer (standardized incidence ratio = 1.3, 95% confidence interval 1.1 to 1.4), ovarian cancer (1.9, 1.3 to 2.8), and hematopoietic malignancies (1.4, 1.0 to 1.8); this latter excess was largely driven by an excess risk of non-Hodgkin's lymphoma (1.8, 1.2 to 2.6). The risk of ovarian cancer was particularly elevated among subjects with a long-standing history of ovarian endometriosis (4.2, 2.0 to 7.7). Cervical cancer risk was slightly reduced (0.7, 0.4 to 1.3) whereas no association was observed for cancer of the endometrium (1.1, 0.6 to 1.9).
CONCLUSIONS: These findings suggest that further attention be given to the risk of breast, ovarian and hematopoietic cancers among women with endometriosis and to exploring possible hormonal and immunologic reasons for the excess risks.

Entities:  

Mesh:

Year:  1997        PMID: 9077609     DOI: 10.1016/s0002-9378(97)70550-7

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  113 in total

Review 1.  Malignant transformation of persistent endometriosis after hysterectomy.

Authors:  Naif A Bawazeer; Hatim M Al-Jifree; Abdulrahim M Gari
Journal:  Saudi Med J       Date:  2014-11       Impact factor: 1.484

Review 2.  Modern trends into the epidemiology and screening of ovarian cancer. Genetic substrate of the sporadic form.

Authors:  Maria Koutsaki; Apostolos Zaravinos; Demetrios A Spandidos
Journal:  Pathol Oncol Res       Date:  2011-12-09       Impact factor: 3.201

Review 3.  Epidemiologic perspective on immune-surveillance in cancer.

Authors:  Daniel W Cramer; Olivera J Finn
Journal:  Curr Opin Immunol       Date:  2011-02-01       Impact factor: 7.486

Review 4.  The Role of Stem Cells in the Etiology and Pathophysiology of Endometriosis.

Authors:  Demetra Hufnagel; Fei Li; Emine Cosar; Graciela Krikun; Hugh S Taylor
Journal:  Semin Reprod Med       Date:  2015-09-16       Impact factor: 1.303

5.  Cancer in women after assisted reproductive technology.

Authors:  Barbara Luke; Morton B Brown; Logan G Spector; Stacey A Missmer; Richard E Leach; Melanie Williams; Lori Koch; Yolanda Smith; Judy E Stern; G David Ball; Maria J Schymura
Journal:  Fertil Steril       Date:  2015-08-10       Impact factor: 7.329

6.  Ovarian cancer risk in relation to medical visits, pelvic examinations and type of health care provider.

Authors:  Haim A Abenhaim; Linda Titus-Ernstoff; Daniel W Cramer
Journal:  CMAJ       Date:  2007-03-27       Impact factor: 8.262

Review 7.  Endometriosis: a high-risk population for major chronic diseases?

Authors:  Marina Kvaskoff; Fan Mu; Kathryn L Terry; Holly R Harris; Elizabeth M Poole; Leslie Farland; Stacey A Missmer
Journal:  Hum Reprod Update       Date:  2015-03-11       Impact factor: 15.610

8.  Endometriosis and ovarian cancer.

Authors:  Milena Králíčková; Vaclav Vetvicka
Journal:  World J Clin Oncol       Date:  2014-12-10

Review 9.  Current understanding of risk factors for ovarian cancer.

Authors:  Thanasak Sueblinvong; Michael E Carney
Journal:  Curr Treat Options Oncol       Date:  2009-07-15

10.  Common variation in the fibroblast growth factor receptor 2 gene is not associated with endometriosis risk.

Authors:  Zhen Zhen Zhao; Pamela M Pollock; Shane Thomas; Susan A Treloar; Dale R Nyholt; Grant W Montgomery
Journal:  Hum Reprod       Date:  2008-02-18       Impact factor: 6.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.